培養肉原料市場 - 全球與區域分析：分析與預測（2023-2028）

隨著越來越多的消費者和食品公司尋求永續的替代蛋白質來源，培養肉原料市場改變食品產業。

培養肉類，也稱為細胞培養肉或實驗室培養肉，代表了食品產業的開創性發展。直接從動物細胞生產肉類為傳統肉類生產提供了永續且合乎道德的替代方案。

隨著世界尋求更永續的蛋白質選擇，培養肉類成分提供了一個引人注目的解決方案。培養肉可以使用植物來源成分作為培養細胞的營養物質來生產，減少對傳統畜牧業的依賴。藻類和微生物可用作培養肉類中具有成本效益且永續的營養來源。

細胞工程在肉類培養中扮演重要角色。開發創新技術來有效分離和培養動物細胞，實現培養肉類的規模化生產。生物反應器對於創造完美的細胞生長環境和實現大規模肉類生產非常重要。

本報告考察了全球培養肉原料市場，並提供了市場概述、依產品、應用、地區分類的趨勢以及進入市場的公司概況。

目錄

第1章 市場

• 產業展望
• 業務動態
• 市場策略與發展
• 商業機會
• 利害關係人分析
• 投資形勢

第2章 應用

• 培養肉原料及設備市場－（依應用）
• 培養肉原料及包裝設備市場需求分析（依應用）

第3章 產品

• 培養肉原料及設備市場-（分產品）
• 培養肉原料及設備市場需求分析（分產品）
• 供應鏈分析/價值鏈分析
• 專利分析

第4章 區域

• 全球市場展望
• 北美洲
• 歐洲
• 亞太地區
• 其他地區

第5章 市場－競爭基準化分析與公司概況

• 競爭基準化分析
  • 競爭力矩陣
  • 市場佔有率分析
• 公司簡介
  • 原料生產商
  • 設備製造商

第6章 調查方法

The Cultured Meat Ingredients Market is experiencing a transformative shift in the food industry, as an increasing number of consumers and food companies seek sustainable and alternative protein sources. This report provides a comprehensive analysis of the Cultured Meat Ingredients Market, focusing on alternate protein sources, cell engineering techniques, and the barriers in the commercialisation of cultivated meat.

Introduction

Cultivated meat, also known as cell-based meat or lab-grown meat, represents a pioneering development in the food industry. It offers a sustainable and ethical alternative to traditional meat production by producing meat directly from animal cells. This report explores the ingredients and technologies that make this innovation possible.

Market Overview

This report provides an overview of the Cultured Meat Ingredients Market, emphasizing its current state and growth prospects.

Market Size and Growth

• Factors driving this growth include increased consumer demand for sustainable and cruelty-free meat products, advancements in cell engineering, and the expanding food-tech industry.

Alternate Protein Sources

As the world seeks more sustainable protein options, cultivated meat ingredients offer a compelling solution.

• Plant-Based Proteins: Cultured meat can be produced using plant-based ingredients as a nutrient source for the cultivated cells, reducing the reliance on traditional livestock farming.

• Algae and Microbes: Algae and microorganisms can serve as a cost-effective and sustainable source of nutrients for cultivated meat, presenting opportunities for ingredient innovation.

Cell Engineering Techniques

Cell engineering plays a crucial role in the cultivation of meat.

• Cell Isolation and Proliferation: Innovative techniques are being developed to isolate and proliferate animal cells efficiently, ensuring the scalable production of cultivated meat.

• Bioreactors: Bioreactors are essential for creating the optimal environment for cell growth, enabling large-scale meat production.

Barriers in the Commercialization of Cultivated Meat

While cultivated meat holds promise, it faces significant challenges on its path to commercialization.

Regulatory Hurdles

• Labelling and Safety Standards: Regulations surrounding labelling, safety, and health standards for cultivated meat need to be established to ensure consumer trust and safety.

• Approval Processes: Streamlining regulatory approval processes is essential to enable the commercialization of cultivated meat products.

Cost and Scalability

• Cost-Effective Production: Reducing the cost of production is vital to make cultivated meat competitive with traditional meat products.

• Scaling Production: Scaling up production while maintaining quality and safety standards is a challenge that needs to be addressed.

Consumer Acceptance

• Cultural Acceptance: Consumer preferences and cultural acceptance of cultivated meat will be crucial for market success.

• Education and Awareness: Initiatives are needed to educate the public about the benefits of cultivated meat and dispel misconceptions.

Table of Contents

1. Markets

• 1.1. Industry Outlook
  • 1.1.1. Market Definition
  • 1.1.2. Alternate Protein Trends
    • 1.1.2.1. Alternate Protein: Current and Future
      • 1.1.2.1.1. Advantages of Alternate Protein in Large-Scale Manufacturing
      • 1.1.2.1.2. Disadvantages of Alternate Protein in Large-Scale Manufacturing
    • 1.1.2.2. Developments in Cell Engineering
    • 1.1.2.3. Exploration of Environmental Benefits of Alternate Protein
    • 1.1.2.4. Emerging Start-ups in the Sector
      • 1.1.2.4.1. Key Countries to Focus
      • 1.1.2.4.2. Research and Development Programs Supported by Governments and Investors
    • 1.1.2.5. Other Industrial Trends
      • 1.1.2.5.1. Hybrid Products
      • 1.1.2.5.2. Fast-Food and Restaurant Partnerships
      • 1.1.2.5.3. Cultured Dairy and Eggs
      • 1.1.2.5.4. Bioinformatics and Data-Driven Approaches
  • 1.1.3. Ecosystem / Ongoing Programs
    • 1.1.3.1. Consortiums and Associations
    • 1.1.3.2. Regulatory Landscape
    • 1.1.3.3. Government Initiatives
  • 1.1.4. Alternate Protein: Cost Analysis

(Note: This section talks about the costs comparison between plant-based, cultivated, and fermented meat alternatives)

• 1.2. Business Dynamics
  • 1.2.1. Business Drivers
  • 1.2.2. Barriers in the Commercialization of Cultivated Meat

(Note: This section covers the scientific/economical/cultural/regulatory barriers faced by Cultured Meat companies)

• 1.2.3. Market Strategies and Developments
  • 1.2.3.1. Business Strategies
    • 1.2.3.1.1. Product Developments
    • 1.2.3.1.2. Market Developments
  • 1.2.3.2. Corporate Strategies
    • 1.2.3.2.1. Mergers & Acquisitions
    • 1.2.3.2.2. Partnerships, Joint Ventures, Collaborations & Alliances
  • 1.2.3.3. Others
• 1.2.4. Business Opportunities

(Note: This segment consists of the analysis of the stakeholders in the Cultured Meat Ingredients and Equipment and equipment market. This will include equipment manufacturers such as Liberation Labs, ingredient manufacturers such as Matrix F.T., and others)

• 1.3. Stakeholder Analysis
• 1.4. Investment Landscape
  • 1.4.1. Key Investors
  • 1.4.2. Major Fundings

2. Application

• 2.1. Cultured Meat Ingredients and Equipment Market - (by Application)
  • 2.1.1. Cultured Meat Ingredients and Equipment Market, by End-User Industry
    • 2.1.1.1. Fermentation
    • 2.1.1.2. Other Alternate Meat Manufacturers
    • 2.1.1.3. Cell Engineering
    • 2.1.1.4. Others

(Note: These are tentative applications. Subject to change as per further research and analysis)

• 2.2. Demand Analysis of Cultured Meat Ingredients and Equipment Market, (by Application)
  • 2.2.1. Demand Analysis of Cultured Meat Ingredients and Equipment Market, by End-User Industry

3. Products

• 3.1. Cultured Meat Ingredients and Equipment Market - (by Product)
  • 3.1.1. Cultured Meat Ingredients and Equipment Market, by Origin
    • 3.1.1.1. Animal-derived (such as Gelatin and Collagen)
    • 3.1.1.2. Plant-derived (such as Cellulose and Alginate)
    • 3.1.1.3. Synthetic (such as Synthetic Peptide Hydrogels)
  • 3.1.2. Cultured Meat Ingredients and Equipment Market, by Type of Starter Cells
    • 3.1.2.1. Skeletal Muscle Stem Cells
    • 3.1.2.2. Fibroblasts
    • 3.1.2.3. Embryonic Stem Cells
    • 3.1.2.4. Others (such as Adipose-Derived Cells, Mesenchymal Stem Cells, and Induced Pluripotent)
• 3.2. Demand Analysis of Cultured Meat Ingredients and Equipment Market, (by Product)
  • 3.2.1. Demand Analysis of Cultured Meat Ingredients and Equipment Market, by Origin
  • 3.2.2. Demand Analysis of Cultured Meat Ingredients and Equipment Market, by Type of Starter Cell
• 3.3. Supply Chain Analysis/Value Chain Analysis

(Note: The report will cover either the Supply Chain Analysis or Value Chain Analysis, depending upon data availability)

• 3.4. Patent Analysis

4. Region

• 4.1. Global Alternate Protein Outlook
• 4.2. North America
  • 4.2.1. North America (by Country)
    • 4.2.1.1. U.S.
    • 4.2.1.2. Canada
    • 4.2.1.3. Rest-of-North America
• 4.3. Europe
  • 4.3.1. Europe (by Country)
    • 4.3.1.1. Netherlands
    • 4.3.1.2. Israel
    • 4.3.1.3. Germany
    • 4.3.1.4. France
    • 4.3.1.5. Rest-of-Europe
• 4.4. U.K.
• 4.5. China
• 4.6. Asia-Pacific
  • 4.6.1. Asia-Pacific (by Country)
    • 4.6.1.1. Japan
    • 4.6.1.2. South Korea
    • 4.6.1.3. Singapore
    • 4.6.1.4. Rest-of-Asia-Pacific
• 4.7. Rest-of-the-World
  • 4.7.1. Rest-of-the-World (by Region)
    • 4.7.1.1. South America
    • 4.7.1.2. Middle East and Africa
      • 4.7.1.2.1. Israel

5. MARKETS -Competitive Benchmarking & Company Profiles

• 5.1. Competitive Benchmarking
  • 5.1.1. Competitive Position Matrix
  • 5.1.2. Market Share Analysis
    • 5.1.2.1. Ingredient Manufacturers
    • 5.1.2.2. Equipment Manufacturers
• 5.2. Company Profiles
  • 5.2.1. Ingredient Manufacturers
    • 5.2.1.1. AMSBIO
      • 5.2.1.1.1. Company Overview
      • 5.2.1.1.2. Product Portfolio
      • 5.2.1.1.3. Customer Profile
        • 5.2.1.1.3.1. Key Customers
        • 5.2.1.1.3.2. Target Customers
      • 5.2.1.1.4. Analyst View

Note: Similar Details will be provided for below mentioned companies.

• 5.2.1.2. Bright Biotech
• 5.2.1.3. BioBetter
• 5.2.1.4. Extracellular
• 5.2.1.5. IntegriCulture Inc.
• 5.2.1.6. Matrix F.T.
• 5.2.1.7. SeaWith Inc.
• 5.2.1.8. Sartorius AG
• 5.2.1.9. Multus Biotechnology

• 5.2.2. Equipment Manufacturers
  • 5.2.2.1. CELLULAR AGRICULTURE LTD
  • 5.2.2.2. Liberation Labs
  • 5.2.2.3. Prolific Machines

6. Research Methodology

• 6.1. Data Sources
  • 6.1.1. Primary Data Sources
  • 6.1.2. Secondary Data Sources
• 6.2. Data Triangulation
• 6.3. Market Estimation & Forecast
  • 6.3.1. Factors for Data Prediction and Modelling